Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling

29 May 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Metabolism and Diseases
Share to Cytokine Signaling Pathways and Interactions
Share to NF-κB Signaling Pathways

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29844572
DOI: 10.1038/s41388-018-0324-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signalingPMID 29844572Read ↗

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cellsSemantic proximity Read ↗

RANK is an independent biomarker of poor prognosis in estrogen receptor-negative breast cancer and a therapeutic target in patient-derived xenograftsSemantic proximity Read ↗

Prevention of breast cancer by RANKL/RANK blockade.Semantic proximity Read ↗

Update on the Role of NFκB in Promoting Aggressive Phenotypes of Estrogen Receptor-Positive Breast Cancer.Semantic proximity Read ↗

Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesisSemantic proximity Read ↗

RANKL and RANK in Cancer TherapySemantic proximity Read ↗

Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers?Semantic proximity Read ↗

RANKL/RANK: from bone loss to the prevention of breast cancer.Semantic proximity Read ↗

RANKL/OPG in Breast Cancer - Extending Its Territory to BRCA Mutation Carriers.Semantic proximity Read ↗

RANKL and RANK: From Mammalian Physiology to Cancer Treatment.Semantic proximity Read ↗

NF-κB at the Crossroads of Normal Mammary Gland Biology and the Pathogenesis and Prevention of BRCA1-Mutated Breast Cancer.Semantic proximity Read ↗

Expression of receptor activator of nuclear factor-kappaB is inversely correlated with metastatic phenotype in breast carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.